Cigna downgraded to Market Perform from Outperform at Bernstein
Bernstein downgraded Cigna (CI) to Market Perform from Outperform with a $323 price target The firm cites underperformance in the company’s ...
Cigna ties pay to customer feedback
Cigna Group says it will tie executive pay to customer satisfaction and hire more employees to help customers facing issues ...
Jim Cramer on The Cigna Group (CI): “Up Six Bucks? I Wouldn’t Buy It”
We recently published a list of Jim Cramer Tells Viewers To Not Trust Billionaires & Discusses These 11 Stocks. In this ...
Medicare Plan's New Deductible Sparks Confusion: What to Know
A specific Medicare Advantage plan has sparked confusion online after a new deductible took effect this year. The Cigna True ...
Benefits Pro3d
Cigna Group announces plans to reform prior authorization, improve service
The Cigna Group will spend up to $150 million to reform its prior authorization, patient advocacy and provider services this ...
Benefits Pro6d
Specialty drugs and cancer surgery claims will push up stop-loss renewal prices, says Cigna CFO
The villains were injectable specialty drugs like Keytruda and inpatient surgical procedures for seriously ill patients.
Truist Financial Reaffirms Their Buy Rating on Cigna (CI)
Truist Financial analyst David S Macdonald reiterated a Buy rating on Cigna (CI – Research Report) today. The company’s shares closed yesterday ...
Connecticut-based Cigna announces plan to reduce prescription-drug costs
Bloomfield-based Cigna announced this week a new initiative that aims to reduce out-of-pocket prescription-drug costs and make those costs more transparent.